Through embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.
Adam Halbridge
Advertisement
Clinical Trial Tokenization Lead and Executive Director, ICON plc
Articles by Adam Halbridge
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
EMD Serono Announces Agreement with Trump Administration Increasing Access to In Vitro Fertilization Therapies for US Patients
2
All of the Medications Announced as Part of FDA’s National Priority Voucher Program
3
Eli Lilly’s and Novo’s Stocks React to President Trump’s Comments on GLP-1 Prices
4
Autonomous Omnichannel: When AI Thinks for Pharma Marketing
5
